We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 10.71%
3 Consumer Discretionary 10.62%
4 Healthcare 9.54%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCKT icon
2401
Hackett Group
HCKT
$278M
$35K ﹤0.01%
1,931
LIND icon
2402
Lindblad Expeditions
LIND
$2.24B
$35K ﹤0.01%
2,177
NKTX icon
2403
Nkarta
NKTX
$165M
$35K ﹤0.01%
1,106
-550
-33% -$15.8K
PRAX icon
2404
Praxis Precision Medicines
PRAX
$10.8B
$35K ﹤0.01%
127
+65
+105% +$23.3K
UVE icon
2405
Universal Insurance Holdings
UVE
$1.18B
$35K ﹤0.01%
2,530
VERU icon
2406
Veru
VERU
$46M
$35K ﹤0.01%
438
NAPA
2407
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$35K ﹤0.01%
+1,583
New +$30.8K
HT
2408
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$35K ﹤0.01%
3,227
KDNY
2409
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$35K ﹤0.01%
2,466
+1,357
+122% +$21.7K
RRD
2410
DELISTED
RR Donnelley & Sons Co.
RRD
$35K ﹤0.01%
+5,556
New +$30.3K
RBNC
2411
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$35K ﹤0.01%
1,251
ZIXI
2412
DELISTED
Zix Corporation
ZIXI
$35K ﹤0.01%
5,001
ALTO icon
2413
Alto Ingredients
ALTO
$315M
$34K ﹤0.01%
+5,608
New +$32.6K
BGRN icon
2414
iShares USD Green Bond ETF
BGRN
$503M
$34K ﹤0.01%
630
+55
+10% +$3K
BW icon
2415
Babcock & Wilcox
BW
$1.39B
$34K ﹤0.01%
+4,352
New +$35.9K
CATO icon
2416
Cato Corp
CATO
$65.7M
$34K ﹤0.01%
2,030
ERNA icon
2417
Eterna Therapeutics
ERNA
$5.16M
0
ESGE icon
2418
iShares ESG Aware MSCI EM ETF
ESGE
$6.86B
$34K ﹤0.01%
760
FEMS icon
2419
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$254M
$34K ﹤0.01%
730
OPRT icon
2420
Oportun Financial
OPRT
$346M
$34K ﹤0.01%
1,717
RGP icon
2421
Resources Connection
RGP
$144M
$34K ﹤0.01%
2,400
TRNS icon
2422
Transcat
TRNS
$888M
$34K ﹤0.01%
601
TWI icon
2423
Titan International
TWI
$450M
$34K ﹤0.01%
+3,959
New +$38.6K
VHT icon
2424
Vanguard Health Care ETF
VHT
$19B
$34K ﹤0.01%
141
VPG icon
2425
Vishay Precision Group
VPG
$908M
$34K ﹤0.01%
1,011

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.